QS Investors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,500
Closed -$223K 1123
2021
Q1
$223K Hold
2,500
﹤0.01% 1084
2020
Q4
$235K Buy
+2,500
New +$220K ﹤0.01% 1067
2019
Q1
Sell
-14
Closed -$2K 1689
2018
Q4
$2K Hold
14
﹤0.01% 1641
2018
Q3
$1K Hold
14
﹤0.01% 1721
2018
Q2
$2K Sell
14
-18
-56% -$1.94K ﹤0.01% 1678
2018
Q1
$3K Hold
32
﹤0.01% 1648
2017
Q4
$4K Sell
32
-2,974
-99% -$308K ﹤0.01% 1614
2017
Q3
$297K Hold
3,006
﹤0.01% 1084
2017
Q2
$267K Buy
3,006
+2,980
+11,462% +$262K ﹤0.01% 1110
2017
Q1
$2K Buy
26
+8
+44% +$689 ﹤0.01% 1700
2016
Q4
$2K Hold
18
﹤0.01% 1499
2016
Q3
$2K Hold
18
﹤0.01% 1483
2016
Q2
$2K Buy
18
+6
+50% +$619 ﹤0.01% 1504
2016
Q1
$1K Hold
12
﹤0.01% 1572
2015
Q4
$1K Buy
+12
New +$1.07K ﹤0.01% 1590

Other funds holding CRI

QS Investors's CRI Position: Q2 2021 in Review

QS Investors sold out of Carter's (CRI) in Q2 2021, closing a stake of 2,500 shares — an estimated $223K sold.

QS Investors first reported a position in CRI in Q4 2015 and held it in 15 quarters. The position peaked at $297K in Q3 2017. 297 funds tracked by Wall St. Rank hold CRI as of Q2 2021.

  • QS Investors reported no remaining Carter's position as of Q2 2021 after selling out during the quarter.
  • QS Investors sold 2,500 Carter's shares in Q2 2021, an estimated $223K.
  • QS Investors first reported a position in Carter's in Q4 2015 and held it in 15 quarters.
  • QS Investors's Carter's position peaked at $297K in Q3 2017.
  • 297 funds tracked by Wall St. Rank held Carter's as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.